文献速递颈动脉与弓上血管

近端颈总动脉或无名动脉病变伴或不伴同侧颈内动脉串联病变的手术结局的系统综述

A Systematic Review of Procedural Outcomes in Patients With Proximal Common Carotid or Innominate Artery Disease With or Without Tandem Ipsilateral Internal Carotid Artery Disease.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-09-11

孤立开放手术治疗近端颈总动脉或无名动脉病变的30天死亡/卒中率高于孤立血管内治疗或杂交联合CEA,但作者提示各组病变构成、患者选择、时代演变和发表偏倚可能影响比较。

要点

  • 杂交组(伴同侧ICA串联病变)30天死亡/卒中为3.3%,晚期同侧卒中6年中位随访为3.3%。
  • 孤立开放手术组30天死亡/卒中为7%,高于孤立血管内组的1.5%。
  • 有症状患者的数据谨慎支持孤立近端CCA/IA病变首选血管内治疗、串联病变采用杂交策略。

核心结论

  • 近端CCA/IA病变行孤立开放手术的操作风险高于孤立血管内治疗或与CEA联合的杂交策略,但该差异可能受病变构成、患者选择、医学治疗演变和发表偏倚影响。
  • 对有症状患者,数据谨慎支持孤立近端CCA/IA病变采用「血管内优先」策略,对近端CCA/IA与ICA串联狭窄采用杂交策略。
  • 对开放手术处理IA和CCA以及无症状患者的任何操作应持谨慎态度。

研究设计与样本

  • 杂交组为开放逆行IA/近端CCA血管成形/支架联合CEA,治疗同侧近端ICA串联病变,n=700。
  • 孤立开放手术组为仅对IA或近端CCA行开放手术(不联合CEA),n=686。
  • 孤立血管内组为仅对IA或近端CCA狭窄行血管内治疗(不联合CEA),n=583。

主要发现

  • 杂交组中66%病变累及近端CCA,30天死亡/卒中为3.3%,中位6年随访晚期同侧卒中为3.3%。
  • 杂交组晚期再狭窄近端CCA/IA为10.5%,ICA为4.1%。
  • 孤立开放手术组中78%病变累及IA,30天死亡/卒中为7%,中位12年随访晚期同侧卒中为1%,主动脉旁路内晚期再狭窄为2.6%。
  • 孤立血管内组中IA占52%、近端CCA占47%,84%经皮完成,30天死亡/卒中为1.5%,中位4年随访晚期同侧卒中为1%,再狭窄率为9%。

关键数值与推荐

  • 杂交组(伴同侧ICA串联病变):30天死亡/卒中3.3%,晚期同侧卒中3.3%(中位6年),近端CCA/IA再狭窄10.5%、ICA再狭窄4.1%。
  • 孤立开放手术组:30天死亡/卒中7%,晚期同侧卒中1%(中位12年),主动脉旁路内再狭窄2.6%。
  • 孤立血管内组:30天死亡/卒中1.5%,晚期同侧卒中1%(中位4年),再狭窄率9%。

临床怎么用

  • 对有症状的孤立近端CCA/IA病变可谨慎考虑血管内治疗优先策略。
  • 对有症状的近端CCA/IA与同侧ICA串联病变可谨慎考虑杂交(血管成形/支架联合CEA)策略。
  • 对开放手术治疗IA和CCA以及无症状患者的任何操作应持谨慎态度。

局限性

  • 可用数据有限,且涉及跨越57年的非常不同的患者组和管理策略。
  • 开放手术组中无名动脉病变比例高于近端CCA,可能解释其较高的并发症/死亡率。
  • 患者选择变化、医学干预的时代演变和发表偏倚可能影响结果比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To establish 30 day and mid term outcomes in patients treated for significant stenoses affecting the proximal common carotid artery (CCA) or innominate artery (IA) with/without tandem disease of the ipsilateral internal carotid artery (ICA). METHODS: Systematic review of early and mid term outcomes in 1 969 patients from 77 studies (1960-2017) who underwent: (i) hybrid open retrograde angioplasty/stenting of the IA/proximal CCA plus carotid endarterectomy (CEA) in patients with tandem disease of the ipsilateral proximal ICA (n = 700); (ii) isolated open surgery to the IA or proximal CCA (no CEA) (n = 686); or (iii) an isolated endovascular approach to IA or proximal CCA stenoses (no CEA) (n = 583). RESULTS: In the hybrid group with tandem disease (66% involving proximal CCA), the 30 day death/stroke was 3.3%, with a late ipsilateral stroke rate of 3.3% at a median six years follow up. Late re-stenosis was 10.5% for proximal CCA/IA and 4.1% for the ICA. In the isolated open surgery group (78% involving the IA), the 30 day death/stroke was 7%, with a late ipsilateral stroke rate of 1% at a median 12 years follow up. Late re-stenosis within aortic bypasses was 2.6%. In the isolated endovascular group (52% IA, 47% proximal CCA), the majority of procedures were done percutaneously (84%), with a 30 day death/stroke rate of 1.5%. Late ipsilateral stroke was 1% at a median four years follow up, with a re-stenosis rate of 9%. CONCLUSION: Procedural risks were higher following isolated open surgical interventions involving the proximal CCA/IA, compared with proximal lesions treated by isolated angioplasty/stenting, or in tandem with CEA. This higher morbidity/mortality may, however, reflect a greater proportion of innominate (vs. proximal CCA) lesions in open surgical series, changes in patient selection, time dependent evolution of medical interventions, and publication bias. The available data were limited and related to very different patient groups and management strategies spanning 57 years. Caution is raised, particularly for open surgery IA and CCA surgery, and for any procedures in asymptomatic patients. In symptomatic patients, the data cautiously support an "endovascular first" strategy for isolated proximal CCA/IA lesions and a hybrid approach for tandem proximal CCA/IA and ICA stenoses.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Robertson V, Poli F, Saratzis A, et al. A Systematic Review of Procedural Outcomes in Patients With Proximal Common Carotid or Innominate Artery Disease With or Without Tandem Ipsilateral Internal Carotid Artery Disease. Eur J Vasc Endovasc Surg. 2020. PMID: 32928666. doi:10.1016/j.ejvs.2020.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。